Keith Hyland

5.4k total citations
87 papers, 3.3k citations indexed

About

Keith Hyland is a scholar working on Clinical Biochemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, Keith Hyland has authored 87 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Clinical Biochemistry, 31 papers in Molecular Biology and 24 papers in Biochemistry. Recurrent topics in Keith Hyland's work include Metabolism and Genetic Disorders (58 papers), Amino Acid Enzymes and Metabolism (24 papers) and Mitochondrial Function and Pathology (16 papers). Keith Hyland is often cited by papers focused on Metabolism and Genetic Disorders (58 papers), Amino Acid Enzymes and Metabolism (24 papers) and Mitochondrial Function and Pathology (16 papers). Keith Hyland collaborates with scholars based in United States, Canada and United Kingdom. Keith Hyland's co-authors include Teodoro Bottiglieri, Simon Heales, Richard P. Allen, Christopher J. Earley, E. H. Reynolds, Robert Surtees, Peter T. Clayton, Christian Auclair, John M. Shoffner and Charles H. Rodeck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Keith Hyland

87 papers receiving 3.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Keith Hyland 1.3k 1.2k 615 597 591 87 3.3k
Russell P. Saneto 1.2k 0.9× 2.3k 2.0× 560 0.9× 171 0.3× 235 0.4× 112 4.1k
Yevgeny Daikhin 1.1k 0.8× 1.5k 1.3× 722 1.2× 568 1.0× 158 0.3× 58 3.3k
Albert Quintana 370 0.3× 2.1k 1.8× 893 1.5× 279 0.5× 319 0.5× 57 4.4k
Lucien Bettendorff 840 0.6× 831 0.7× 421 0.7× 1.2k 2.1× 2.0k 3.4× 108 3.5k
Pınar Coşkun 770 0.6× 3.4k 2.9× 403 0.7× 203 0.3× 220 0.4× 34 4.9k
Karin Ekberg 418 0.3× 1.6k 1.4× 174 0.3× 165 0.3× 116 0.2× 69 4.1k
J. Tyson Tildón 617 0.5× 1.2k 1.0× 805 1.3× 288 0.5× 70 0.1× 87 2.9k
Еlena Kosenko 524 0.4× 931 0.8× 616 1.0× 252 0.4× 203 0.3× 112 2.9k
Jan Lewerenz 105 0.1× 1.9k 1.7× 950 1.5× 489 0.8× 974 1.6× 79 4.5k
A. Barbeau 334 0.3× 1.6k 1.4× 2.1k 3.5× 261 0.4× 981 1.7× 171 3.6k

Countries citing papers authored by Keith Hyland

Since Specialization
Citations

This map shows the geographic impact of Keith Hyland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Hyland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Hyland more than expected).

Fields of papers citing papers by Keith Hyland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Hyland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Hyland. The network helps show where Keith Hyland may publish in the future.

Co-authorship network of co-authors of Keith Hyland

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Hyland. A scholar is included among the top collaborators of Keith Hyland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Hyland. Keith Hyland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Lisa, Keith Hyland, Marion A. Hughes, et al.. (2022). Metabolomic disorders: confirmed presence of potentially treatable abnormalities in patients with treatment refractory depression and suicidal behavior. Psychological Medicine. 53(13). 6046–6054. 9 indexed citations
4.
D׳Aco, Kristin, David Bearden, David Watkins, et al.. (2014). Severe 5,10-Methylenetetrahydrofolate Reductase Deficiency and Two MTHFR Variants in an Adolescent With Progressive Myoclonic Epilepsy. Pediatric Neurology. 51(2). 266–270. 16 indexed citations
5.
DeCuypere, Michael, et al.. (2012). Altered Serotonin, Dopamine and Norepinepherine Levels in 15q Duplication and Angelman Syndrome Mouse Models. PLoS ONE. 7(8). e43030–e43030. 35 indexed citations
6.
Veerapandiyan, Aravindhan, William B. Gallentine, Edward C. Smith, et al.. (2011). Electroencephalographic and seizure manifestations of pyridoxal 5′-phosphate-dependent epilepsy. Epilepsy & Behavior. 20(3). 494–501. 29 indexed citations
8.
Gallagher, Renata C., Johan L.K. Van Hove, Gunter Scharer, et al.. (2009). Folinic acid–responsive seizures are identical to pyridoxine‐dependent epilepsy. Annals of Neurology. 65(5). 550–556. 117 indexed citations
9.
Hyland, Keith. (2007). Inherited Disorders Affecting Dopamine and Serotonin: Critical Neurotransmitters Derived from Aromatic Amino Acids. Journal of Nutrition. 137(6). 1568S–1572S. 58 indexed citations
10.
Kweon, Gi‐Ryang, Jeremy D. Marks, Robert Krencik, et al.. (2004). Distinct Mechanisms of Neurodegeneration Induced by Chronic Complex I Inhibition in Dopaminergic and Non-dopaminergic Cells. Journal of Biological Chemistry. 279(50). 51783–51792. 62 indexed citations
11.
Hyland, Keith, et al.. (2003). Thehph-1 mouse: A model for dominantly inherited GTP-cyclohydrolase deficiency. Annals of Neurology. 54(S6). S46–S48. 40 indexed citations
12.
Earley, Christopher J., Keith Hyland, & Richard P. Allen. (2001). CSF dopamine, serotonin, and biopterin metabolites in patients with restless legs syndrome. Movement Disorders. 16(1). 144–149. 52 indexed citations
13.
Greene, Paul, Susan Bressman, Blair Ford, & Keith Hyland. (2000). Parkinsonism, dystonia, and hemiatrophy. Movement Disorders. 15(3). 537–541. 12 indexed citations
14.
Hyland, Keith, Blaine L. Beaman, Peter A. LeWitt, & A. J. DeMaggio. (2000). Monoamine Changes in the Brain of BALB/c Mice Following Sub-Lethal Infection with Nocardia asteroides (GUH-2). Neurochemical Research. 25(4). 443–448. 13 indexed citations
15.
Griener, James C., Keith Hyland, Teodoro Bottiglieri, et al.. (1999). Plasma Homocysteine Levels and Folate Status in Children With Sickle Cell Anemia. Journal of Pediatric Hematology/Oncology. 21(3). 219–223. 27 indexed citations
16.
Shimoji, Mika, Kei Hirayama, Keith Hyland, & Gregory Kapatos. (1999). GTP Cyclohydrolase I Gene Expression in the Brains of Male and Female hph‐1 Mice. Journal of Neurochemistry. 72(2). 757–764. 39 indexed citations
17.
Heuvel, Lambert P.W.J. van den, Jan Smeıtınk, J.F. de Rijk-van Andel, et al.. (1998). A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population. Human Genetics. 102(6). 644–646. 79 indexed citations
18.
Kish, Stephen J., Richard D. Jacobson, Julie S. Fryburg, et al.. (1998). Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations. Annals of Neurology. 44(1). 10–16. 116 indexed citations
19.
Metz, J., Katherine McGrath, Michael J. Bennett, Keith Hyland, & Teodoro Bottiglieri. (1995). Biochemical indices of vitamin B12 nutrition in pregnant patients with subnormal serum vitamin B12 levels. American Journal of Hematology. 48(4). 251–255. 56 indexed citations
20.
Hyland, Keith, Robert Surtees, Simon Heales, et al.. (1993). Cerebrospinal Fluid Concentrations of Pterins and Metabolites of Serotonin and Dopamine in a Pediatric Reference Population. Pediatric Research. 34(1). 10–14. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026